EULAR Advocacy Committee
The EULAR Advocacy Committee engages with the EU as well as other national political institutions as a recognised partner and source of expertise in rheumatic and musculoskeletal diseases. The Committee fights for the recognition of the needs of people with rheumatic and musculoskeletal diseases (RMDs) by advocating research and education in rheumatology, promoting the EULAR brand as a reliable source of information, coordinating the work of the Sub-Committee(s) (Communication), and providing strategic guidance on all EULAR messages to internal and external audiences.
Communications Sub-Committee Regulations
Chair: Prof. Margreet Kloppenburg, Netherlands
Past-chair:
Prof. Loreto Carmona, Spain
EMA Liaison: Prof. Marta Mosca, Italy
BioMed Alliance Liaison: Prof. Annamaria Iagnocco, Italy
Advisor: Prof. Gerd Burmester, Germany & Prof. Annamaria Iagnocco, Italy
Consultant: Rory Douglas Home, UK/Belgium & Frans Green, UK/Belgium
Sub-Committee Chair: Anna Voormann, Germany
Committee Members
|
Loreto Carmona, Spain Mandate duration: Jun-21 - Jun-25 Margreet Kloppenburg, Netherlands Mandate duration: Jun-23 - Jun-27 Annamaria Iagnocco, Italy Mandate duration: Jun-23 - Jun-27 Andri Phoka, Cyprus Mandate duration: Jun-21 - Jun-25 Sina Bugeja, Malta Mandate duration: Jun-23 - Jun-27 Fernando Estevez-Lopez, Spain Mandate duration: Jun-21 - Jun-25 Thea Vliet-Vlieland, Netherlands Mandate duration: Jun-23 - Jun-27 Xabier Michelena Vegas, Spain Mandate duration: Jun-23 - Jun-27 Olena Zimba, Portugal Mandate duration: Jun-23 - Jun-27 Jelena Vojinovic, Serbia Mandate duration: Jun-23 - Jun-27 Philipp Sewerin, Germany Mandate duration: Jun-23 - Jun-27 Ayhan Dinc, Turkey Mandate duration: Jun-21 - Jun-25 Razvan Ionescu, Romania Mandate duration: Jun-23 - Jun-27 Lidia Teixeira, Portugal Mandate duration: Jun-21 - Jun-25 Zoltan Szekanecz, Hugary Mandate duration: Jun-23 - Jun-27 Elena Nikiphorou, UK Mandate duration: Jun-21 - Jun-25 Ricardo Ferreira, Portugal Mandate duration: Jun-23 - Jun-27 Oliver Hendricks, Denmark Mandate duration: Jun-23 - Jun-27 Pia Isomaki, Finland Mandate duration: Jun-23 - Jun-27 Rikke Moe, Norway Mandate duration: Jun-21 - Jun-25 Laure Gossec, France Mandate duration: Jun-23 - Jun-27 |
EULAR Communications Sub-Committee
The Communications Sub-Committee supports EULAR's and the Committee's objective and has the following aims:
- provide strategic advice on EULAR communications, such as the EULAR communication plan, website and other digital communications, PR campaigns, EULAR App and emerging products;
- provide strategic advice on all aspects regarding the official EULAR publications (Annals of the Rheumatic Diseases), such as policies in academic publishing, advertising, applications for Editor of journal, contract with the publisher, ethical policies (e.g. duplicate publication, plagiarism, conflict of interest, etc.).
The Sub-Committee does not pursue gainful or self-help purposes.
Sub-Committee Chair: Anna Voormann, Germany,
Mandate duration: Jun-23 - Jun-25
Sub-Committee Members
Deshire Alpizar, Mexico
Francis Berenbaum, France
Johannes Bijlsma, Netherlands
Nele Caeyers, Belgium
Mrinalini Dey, United Kingdom
Oliver Hendricks, Denmark
Helena Marzo-Ortega, United Kingdom, Spain
Rikke Moe, Norway
Edoardo Prediletto, United Kingdom
Paul Studenic, Austria
Related Information
EULAR Advocacy Newsletter
EULAR is committed to bringing rheumatic and musculoskeletal diseases (RMDs) onto the EU's agenda. Sign up to the EULAR Advocacy newsletter to keep up with the changes that our organisation is working towards in the area of policy and legislation to help achieve better social and economic outcomes for the many millions of people affected by these chronic and debilitating diseases across Europe.
EULAR Project Proposals
All EULAR project proposals are to be submitted by 15 January or 01 July of each year and is subject to the approval of the EULAR Council. The final decision and budget of a project will be determined by the EULAR Council each March and September.
Download the EULAR Project Proposal template
Submit your proposal to:
eular@eular.org
About EULAR Advocacy
EU Advocacy is a key activity for a European umbrella organisation like the European Alliance of Associations for Rheumatology (EULAR).
EULAR Advocacy Partnerships
EULAR is committed to partner with organisations and scientific medical societies at a EU and national level towards improving research funding, social policy legislation and quality of care; assisting advocacy actions on the national and international levels around rheumatic and musculoskeletal diseases (RMDs).
EULAR Advocacy Activities and Materials
In order to persuade governmental and EU key decision-makers supporting the European rheumatology community, EULAR Advocacy develops evidence-based materials about RMDs and communicates its position on key policies and legislation being discussed.
EULAR Policy Statements
As part of its advocacy activities, EULAR produces and adopts a number of documents and declarations that are used to express EULAR’s position and/or demands on different policy issues.
EU Parliament Interest Group on RMDs
The European Parliament Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs) was created in 2009 on the occasion of World Arthritis Day (12 October) and was re-established during the current parliamentary term (2014-2019).
Links to Other Organisations
Partnerships that help to increase the knowledge of the organisations involved and the impact they can have on the political stage.
RMD Definition
EULAR description on Rheumatic and Musculoskeletal Diseases (RMDs)
EULAR Statutes, Reports, and By-Laws
The official statutes of the European Alliance of Associations for Rheumatology, EULAR
EULAR Committees
Established by the Board, Committees are set up to manage and perform the various activities of EULAR on behalf of the Council.